Search details
1.
Comparative proteome analysis identified CD44 as a possible serum marker for docetaxel resistance in castration-resistant prostate cancer.
J Cell Mol Med
; 26(4): 1332-1337, 2022 02.
Article
in English
| MEDLINE | ID: mdl-34970839
2.
Proteome profiling of enzalutamide-resistant cell lines and serum analysis identified ALCAM as marker of resistance in castration-resistant prostate cancer.
Int J Cancer
; 151(8): 1405-1419, 2022 10 15.
Article
in English
| MEDLINE | ID: mdl-35689436
3.
Plasma Proteomics Enable Differentiation of Lung Adenocarcinoma from Chronic Obstructive Pulmonary Disease (COPD).
Int J Mol Sci
; 23(19)2022 Sep 24.
Article
in English
| MEDLINE | ID: mdl-36232544
4.
Integrated Fourier Transform Infrared Imaging and Proteomics for Identification of a Candidate Histochemical Biomarker in Bladder Cancer.
Am J Pathol
; 189(3): 619-631, 2019 03.
Article
in English
| MEDLINE | ID: mdl-30770125
5.
Quantitative Secretome Analysis of Activated Jurkat Cells Using Click Chemistry-Based Enrichment of Secreted Glycoproteins.
J Proteome Res
; 16(1): 137-146, 2017 01 06.
Article
in English
| MEDLINE | ID: mdl-27696881
6.
Pancreatic cancer acquires resistance to MAPK pathway inhibition by clonal expansion and adaptive DNA hypermethylation.
Clin Epigenetics
; 16(1): 13, 2024 01 16.
Article
in English
| MEDLINE | ID: mdl-38229153
7.
Comparative proteome and serum analysis identified FSCN1 as a marker of abiraterone resistance in castration-resistant prostate cancer.
Prostate Cancer Prostatic Dis
; 2023 Aug 26.
Article
in English
| MEDLINE | ID: mdl-37634036
8.
Application of Label-Free Proteomics for Quantitative Analysis of Urothelial Carcinoma and Cystitis Tissue.
Methods Mol Biol
; 2228: 283-292, 2021.
Article
in English
| MEDLINE | ID: mdl-33950498
Results
1 -
8
de 8
1
Next >
>>